Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genotyping technologies: application to biotransformation enzyme genetic polymorphism screening.

Marjorie Romkes1, Shama C Buch

  • 1Center for Clinical Pharmacology, University of Pittsburgh, PA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|October 27, 2004
PubMed
Summary

Pharmacogenomics explores genetic variations impacting drug responses and disease. This review details advanced single-nucleotide polymorphism (SNP) genotyping technologies, comparing their effectiveness and limitations for personalized medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy.

Scientific reports·2019
Same author

Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.

Neoplasia (New York, N.Y.)·2015
Same author

Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2015
Same author

MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603.

Clinical epigenetics·2015
Same author

15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers.

Journal of the National Cancer Institute·2015
Same author

Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma.

Cancer letters·2014

Area of Science:

  • Pharmacogenomics
  • Genetics
  • Molecular Biology

Background:

  • Pharmacogenomics investigates genetic variations influencing drug efficacy and disease risk.
  • Single-nucleotide polymorphisms (SNPs) are the most prevalent human genetic variations.
  • Understanding genotype-phenotype associations is crucial for personalized medicine.

Purpose of the Study:

  • To provide an overview of various genotyping technologies for SNP detection.
  • To emphasize recently developed methodologies in SNP detection.
  • To compare the advantages, applicability, cost-efficiency, and limitations of different genotyping methods.

Main Methods:

  • Review of conventional techniques (PCR, mass spectrometry, sequencing) with modifications.
  • Exploration of innovative technologies (FRET, microarrays) for SNP detection.

Related Experiment Videos

  • Comparative analysis based on SNP number, sample size, cost, and limitations.

    • Main Results:

    • Multiple novel approaches for SNP detection are available.
    • Method selection depends on the scale of SNP screening and sample size.
    • Recently developed methods offer improved efficiency and applicability.

    Conclusions:

    • A variety of genotyping technologies exist for SNP analysis.
    • Emerging technologies provide advanced options for genetic variation detection.
    • Informed selection of genotyping methods is key for effective pharmacogenomic research.